Trials / Completed
CompletedNCT00558818
Long-term Study With Clevudine
A Phase lV Study to Evaluate the Long-term Safety and Efficacy of Clevudine in the Patients Chronically Infected With Hepatitis B Virus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Bukwang Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
A open-labeled phase lV study with 96 weeks of treatment period. The purpose of this study is to investigate safety and efficacy of clevudine in patients chronically infected with hepatitis B virus, HBeAg positive or negative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clevudine | clevudine 30 mg qd |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2007-11-15
- Last updated
- 2012-07-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00558818. Inclusion in this directory is not an endorsement.